StonvexLoading…
StonvexStonvexStonvexCore line items from HCSG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.84B | $1.72B | $1.67B | $1.69B |
Operating Income | $67.87M | $52.94M | $53.06M | $44.55M |
Net Income | $59.06M | $39.47M | $38.39M | $34.24M |
EPS (Diluted) | $0.81 | $0.53 | $0.52 | $0.46 |
Total Assets | $794.25M | $802.77M | $790.65M | $720.84M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $125.19M | $56.78M | $54.33M | $26.28M |
Free Cash Flow OCF − CapEx | $139.15M | $24.47M | $38.09M | $-13.38M |
Shares Outstanding | 69.60M | 73.20M | 73.34M | 74.09M |